Low, S. K., Fujiwara, Y., Nishizaki, D., Jensen, T. J., Seager, R., DePietro, P., Kato, S., Kurzrock, R. (2026). High expression of CIITA, the master MHC-II regulator, as a predictor of survival benefit from immune checkpoint inhibitors across solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e14589